Live from the NIH registry
Studies recruiting near Bakersfield right now
Top 25 of 68 recruiting studies, sorted by proximity — each links to its official registry page
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 2
Interventional 300 participants sought
Trovare Clinical Research - Bakersfield CA — Bakersfield, California (1.7 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
Solid Tumor
Phase 1, Phase 2
Interventional 100 participants sought
CBCC Global Research Site 005 — Bakersfield, California (1.7 mi)
· Sponsor: Alyssum Therapeutics
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Pruritus
Phase 3
Interventional 284 participants sought
Kern Allergy and Medical Research- Site Number : 8400016 — Bakersfield, California (1.7 mi)
· Sponsor: Sanofi
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
California Retina Consultants-Bakersfield-65523 — Bakersfield, California (1.7 mi)
· Sponsor: Boehringer Ingelheim
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Neovascular Age-Related Macular Degeneration
Phase 3
Interventional 1,000 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: Hoffmann-La Roche
A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma
Asthma
Phase 3
Interventional 1,100 participants sought
Kern Research, Inc. — Bakersfield, California (1.7 mi)
· Sponsor: Pfizer
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Melanoma Stage IV, Solid Tumor
Phase 1, Phase 2
Interventional 117 participants sought
Comprehensive Blood and Cancer Center — Bakersfield, California (1.7 mi)
· Sponsor: Georgiamune Inc
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Retinitis Pigmentosa
Phase 2
Interventional 60 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: jCyte, Inc
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Breast Cancer, Metastatic Breast Cancer
Phase 3
Interventional 404 participants sought
Comprehensive Blood and Cancer Center — Bakersfield, California (1.7 mi)
· Sponsor: BriaCell Therapeutics Corporation
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
Phase 3
Interventional 500 participants sought
CBCC Global Research - Comprehensive Blood & Cancer Center — Bakersfield, California (1.7 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Diabetic Macular Edema, DME
Phase 3
Interventional 240 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: EyePoint Pharmaceuticals, Inc.
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
COVID-19 SARS-CoV-2 Infection
Phase 3
Interventional 2,330 participants sought
National Institute of Clinical Research - Bakersfield — Bakersfield, California (1.7 mi)
· Sponsor: Pfizer
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
Benign Prostatic Hyperplasia
N/A
Interventional 215 participants sought
Michael G Oefelein Clinical Trials — Bakersfield, California (1.7 mi)
· Sponsor: Rivermark Medical
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Non-Muscle Invasive Bladder Cancer
Phase 1, Phase 2
Interventional 32 participants sought
Michael G Oefelein Clinical Trials ( Site 0053) — Bakersfield, California (1.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Severe Asthma
Phase 3
Interventional 786 participants sought
Research Site 13 — Bakersfield, California (1.7 mi)
· Sponsor: Generate Biomedicines
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Non-Muscle Invasive Bladder Urothelial Carcinoma, Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma
Phase 2
Interventional 160 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
ADARx Clinical Site — Bakersfield, California (1.7 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Astrocytoma, IDH-Mutant, Grade 3
Phase 3
Interventional 408 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
Macular Edema Secondary to Inflammation
Phase 3
Interventional 300 participants sought
California Retina Consultants (Bakersfield) — Bakersfield, California (1.7 mi)
· Sponsor: Kodiak Sciences Inc
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
AMD, nAMD
Phase 3
Interventional 714 participants sought
California Retina Consultants - Bakersfield /ID# 256240 — Bakersfield, California (1.7 mi)
· Sponsor: AbbVie
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
Kern Research, Inc. — Bakersfield, California (1.7 mi)
· Sponsor: Celldex Therapeutics
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
Asthma
Phase 2
Interventional 69 participants sought
Research Site — Bakersfield, California (1.7 mi)
· Sponsor: AstraZeneca
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
HIV Infections
Phase 2
Interventional 186 participants sought
GSK Investigational Site — Bakersfield, California (1.7 mi)
· Sponsor: ViiV Healthcare